Gene Therapy for Blindness Caused by Choroideremia

NCT01461213 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
14
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of Oxford

Collaborators